Summary
A 32-year-old web consultant was granted a security clearance under Guideline H (Drug Involvement) despite allegations of past drug use. The Statement of Reasons cited his use of ecstasy once between 2000 and 2002, and three confirmed uses of marijuana between 1999 and 2008. These actions raised disqualifying conditions under Adjudicative Guidelines paragraphs 25(a) and 25(c).
However, the judge found that the applicant successfully mitigated these security concerns. Mitigating conditions applied included Adjudicative Guidelines paragraphs 26(a), 26(b), and 26(d). The decision to grant the clearance was based on several factors.
The applicant's drug use was infrequent and occurred many years prior to the clearance application. He demonstrated a clear and convincing intent to abstain from future drug use, including actively disassociating from friends who used drugs. Furthermore, expert testimony presented during the proceedings indicated a very low probability of any future drug involvement by the applicant.
Why the Applicant Prevailed
- The applicant's drug use was infrequent and occurred many years ago.
- He demonstrated a clear intent to avoid future drug use, including disassociating from drug-using friends.
- Expert testimony indicated a very low probability of future drug use.
Conditions Referenced
- AG ¶ 25(a)raisedAny Drug Abuse
- AG ¶ 25(c)raisedIllegal Drug Possession
- AG ¶ 26(a)appliedBehavior Happened Long Ago or Infrequently
- AG ¶ 26(b)appliedDemonstrated Intent Not to Abuse Drugs in the Future
- AG ¶ 26(d)appliedCompletion of a Drug Treatment ProgramThe applicant underwent an evaluation by a qualified professional who found no evidence of drug abuse.
Key Rule Quoted
“A security clearance decision is intended only to resolve the questions of whether it is clearly consistent with the national interest for an applicant to either receive or continue to have access to classified information.”
Procedural Posture
- SOR issuedAug 21, 2009
- Answer filedOct 7, 2009
- Hearing heldJan 6, 2010
- Decision dateFeb 26, 2010
Cite For
- Mitigation of Drug Involvement Under Guideline H
- Consideration of Infrequent Drug Use in the Past
- Importance of Expert Evaluation in Assessing Drug Use Risks